Volume 28, Issue 3 | Heart Failure Reviews

Search all Heart Failure Reviews articles

Volume 28, Issue 3

May 2023

Diabetes in Heart Failure

Issue Editors:

Alberto Palazzuoli,
Gianluigi Savarese

15 articles in this issue

An update on diabetes spectrum in heart failure: current evidence and potential therapeutic applications
Alberto Palazzuoli
Gianluigi Savarese
ReviewPaper 24 January 2022 Pages: 573 - 575
Prognostic impact of diabetes in chronic and acute heart failure
Stefano Ghio
Valentina Mercurio
Stefania Paolillo
ReviewPaper 22 November 2021 Pages: 577 - 583
Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence
Alberto Palazzuoli
Massimo Iacoviello
ReviewPaper Open access 06 May 2022 Pages: 585 - 596
Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants
Francesca Romana Prandi
Isabella Evangelista
Francesco Romeo
ReviewPaper 10 January 2022 Pages: 597 - 606
Redefining diabetes mellitus treatments according to different mechanisms beyond hypoglycaemic effect
Savina Nodari
Francesco Fioretti
Francesco Barilla
ReviewPaper 08 February 2022 Pages: 607 - 625
Diabetes-induced chronic heart failure is due to defects in calcium transporting and regulatory contractile proteins: cellular and molecular evidence
Sunil Rupee
Khemraj Rupee
Jaipaul Singh
ReviewPaper 15 September 2022 Pages: 627 - 644
Impact of diabetes on cardiopulmonary function: the added value of a combined cardiopulmonary and echocardiography stress test
Nicola Riccardo Pugliese
Alessandra Pieroni
Frank Lloyd Dini
ReviewPaper 24 November 2021 Pages: 645 - 655
Use of disease-modifying drugs in diabetic patients with heart failure with reduced ejection fraction
Daniele Masarone
Roberta Pacileo
Giuseppe Pacileo
ReviewPaper 03 November 2021 Pages: 657 - 665
Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond
Angela Sciacqua
Elena Succurro
Giorgio Sesti
ReviewPaper 02 December 2021 Pages: 667 - 681
Diabetes and SGLT2-iss inhibitors in patients with heart failure with preserved or mid-range left ventricular ejection fractions
Andrea Passantino
Caterina Rizzo
Alberto Palazzuoli
ReviewPaper 01 November 2021 Pages: 683 - 695
Effects of SGLT2 inhibitors on cardiac structure and function
Giuseppina Novo
Tommaso Guarino
Erberto Carluccio
ReviewPaper 16 June 2022 Pages: 697 - 707
Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient
Paolo Severino
Andrea D’Amato
Francesco Fedele
ReviewPaper Open access 16 October 2021 Pages: 709 - 721
Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes
Edoardo G. Gronda
Emilio Vanoli
Domenico Gabrielli
ReviewPaper 31 January 2022 Pages: 723 - 732
Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients
Michele Correale
Olga Lamacchia
Natale Daniele Brunetti
ReviewPaper 11 August 2021 Pages: 733 - 744
Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension
Federico Luongo
Cristiano Miotti
Roberto Badagliacca
ReviewPaper 31 January 2022 Pages: 745 - 755